TEST Job - Study Nurse - UK B'ham Site
Patients meet you before they meet the medicine. Join our Birmingham site as a Study Nurse.
About FutureMeds
We run clinical research sites across Europe, giving patients access to new treatments and helping bring medicines to the people who need them. Our teams work with patients directly, every day, at sites in the UK, Germany, Spain, Poland, Bulgaria and Ukraine.
About the role
As a Study Nurse at our Birmingham site you will care for patients taking part in clinical trials. You will run study visits, take samples, record data accurately, and be the person our patients see and trust throughout their time with us.
What you will need
Registered nurse with a current NMC registration. Good attention to detail and comfortable working to a protocol. Patient-centred and calm under pressure. Previous clinical research experience is useful but not essential, we will train you.
What we offer
A role where accuracy matters and patients come first. Training and support to move into clinical research if you are new to it. A team that looks after each other.
How our process works
A short call with one of our team, around 20 minutes. Then an interview at the site. Then a final conversation. We aim to come back to you within 10 working days at each stage, and we will always tell you either way.
If you need any adjustments at any point in the process, tell us and we will sort it.
- Department
- Nursing
- Role
- Study Nurse
- Location
- Birmingham
- Salary
- £38,000/year
- Employment type
- Full-time
About FutureMeds
FutureMeds is an independent, fully-owned European Site Network and DCT service provider dedicated to running patient-centric clinical trials and delivering quality data for the world’s leading Sponsors & CROs.
With strategically located sites across Europe, over 220 experienced investigators, and more than 1400 homecare providers, FutureMeds offers site and DCT solutions across most therapeutic areas and provides reliability, efficiency and accuracy to help clients accelerate patient access to new treatments.